Company: LCTX
Filing Date: 2025-07-02
Form Type: 8-K
Source: 0000950170-25-093007
Chunk: 2

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-07-02
Form: 8-K
Item: Item 5.07
Chunk 2
---
 as set forth in the Proxy Statement, by the following votes:

   Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────────────
  96,071,162          3,804,451          611,814            59,813,557  

4. Shareholders approved the EIP Amendment by the votes set forth below.:

   Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────────────
  88,575,737         11,560,925          350,765            59,813,557